Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Nature of Business (Details)

v3.22.4
Nature of Business (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Write off of COVID-19 PCR testing inventory and equipment $ 6,100 $ 0 $ 6,061 $ 0
Write off of remaining COVID-19 PCR testing inventory     5,300  
PCR testing equipment, general and administrative     800  
Grant income recognized, COVID-19   0 0 7,900
Accrued deferred social security taxes, COVID-19     3,000  
Amount of ERTC recognized, COVID-19   $ 0 $ 4,400 $ 1,900